A proteolytic fragment from the central region of p53 has marked sequencespecific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein, Genes Dev, vol.7, pp.2565-2574, 1993. ,
Sitespecific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53, Genes Dev, vol.6, pp.1886-1898, 1992. ,
The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity, Proc. Natl. Acad. Sci. USA, vol.92, pp.5729-5733, 1995. ,
Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP, Oncogene, vol.9, pp.1775-1780, 1994. ,
Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, vol.377, pp.646-649, 1995. ,
Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity, Oncogene, vol.15, pp.807-816, 1997. ,
Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein, J. Biol. Chem, vol.270, pp.25014-25019, 1995. ,
Modulation of activity of the promoter of the human MDR1 gene by ras and p53, Science, vol.255, pp.459-462, 1992. ,
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science, vol.265, pp.346-355, 1994. ,
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR, Science, vol.265, pp.386-394, 1994. ,
Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells, J. Virol, vol.66, pp.6164-6170, 1992. ,
Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay, Oncogene, vol.16, pp.2627-2539, 1998. ,
Wild-type p53 activates transcription in vitro, Nature, vol.358, pp.83-86, 1992. ,
Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein, Nucleic Acids Res, vol.24, pp.4281-4288, 1996. ,
Presence of a potent transcription activating sequence in the p53 protein, Science, vol.249, pp.1046-1049, 1990. ,
A simple p53 functional assay for screening cell lines, blood, and tumors, Proc. Natl. Acad. Sci. USA, vol.92, pp.3963-3967, 1995. ,
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent, Oncogene, vol.10, pp.2103-2111, 1995. ,
Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain, Mol. Cell. Biol, vol.18, pp.3735-3743, 1998. ,
A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis, Mol. Cell. Biol, vol.16, pp.4961-4971, 1996. ,
The p53 protein is an unusually shaped tetramer that binds directly to DNA, Proc. Natl. Acad. Sci. USA, vol.90, pp.3319-3323, 1993. ,
Genomic effects of the putative oncogene G alpha s. Chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells, J. Biol. Chem, vol.269, pp.22663-22671, 1994. ,
, Biochim. Biophys. Acta, vol.1287, pp.77-102, 1996.
An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control, Proc. Natl. Acad. Sci. USA, vol.95, pp.5166-5171, 1998. ,
, Methods in enzymology, vol.194, 1991.
Mutant p53 proteins behave in a dominant, negative fashion in vivo, Anticancer Res, vol.14, pp.1853-1860, 1994. ,
Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA, EMBO J, vol.12, pp.1021-1028, 1993. ,
Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants, EMBO J, vol.12, pp.5057-5064, 1993. ,
Apoptosis: molecular regulation of cell death, Eur. J. Biochem, vol.236, pp.1-26, 1996. ,
Screening patients for heterozygous p53 mutations using a functional assay in yeast, Nat. Genet, vol.5, pp.124-129, 1993. ,
Identification of redox/repair protein Ref-1 as a potent activator of p53, Genes Dev, vol.11, pp.558-570, 1997. ,
Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science, vol.267, pp.1498-1502, 1995. ,
p73 is a human p53-related protein that can induce apoptosis, Nature, vol.389, pp.191-194, 1997. ,
,
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, vol.90, pp.809-819, 1997. ,
Identification of p53 as a sequence-specific DNAbinding protein, Science, vol.252, pp.1708-1711, 1991. ,
Oncogenic forms of p53 inhibit p53-regulated gene expression, Science, vol.256, pp.827-830, 1992. ,
Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression, Oncogene, vol.9, pp.963-969, 1994. ,
p53: puzzle and paradigm, Genes Dev, vol.10, pp.1054-1072, 1996. ,
A rapid, quantitative and inexpensive method for detecting apoptosis by flow cytometry in transiently transfected cells, Nucleic Acids Res, vol.25, pp.4855-4857, 1997. ,
Solution structure of the tetrameric minimum transforming domain of p53, Nat. Struct. Biol, vol.1, pp.877-890, 1994. ,
Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein, Exp. Cell Res, vol.234, pp.270-276, 1997. ,
p53, the cellular gatekeeper for growth and division, Cell, vol.88, pp.323-331, 1997. ,
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53, Mol. Cell. Biol, vol.16, pp.6009-6019, 1996. ,
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function, Mol. Cell. Biol, vol.16, pp.4952-4960, 1996. ,
Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species, J. Biol. Chem, vol.268, pp.15096-15100, 1993. ,
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53, Cell, vol.62, pp.671-680, 1990. ,
Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription, Oncogene, vol.8, pp.1815-1824, 1993. ,
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation, Cell, vol.65, pp.765-774, 1991. ,
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes, Mol. Cell. Biol, vol.11, pp.12-19, 1991. ,
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, pp.293-299, 1995. ,
Cloning and functional analysis of human p51, which structurally and functionally resembles p53, Nat. Med, vol.4, pp.839-843, 1998. ,
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots, Genes Dev, vol.7, pp.2556-2564, 1993. ,
P73?, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells, Int. J. Oncol, vol.13, pp.5-9, 1998. ,
Activators and targets, Nature, vol.346, pp.329-331, 1990. ,
Role of cysteine residues in regulation of p53 function, Mol. Cell. Biol, vol.15, pp.3892-3903, 1995. ,
Transcriptional activation by wild-type p53 but not transforming mutants of the p53 anti-oncogene, Science, vol.249, pp.1049-1051, 1990. ,
Analysis of p53 mutants for transcriptional activity, Mol. Cell. Biol, vol.11, pp.6067-6074, 1991. ,
The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation, Proc. Natl. Acad. Sci. USA, vol.92, pp.9455-9459, 1995. ,
Laboratory course manual for methods in yeast genetics, 1990. ,
A novel protein with strong homology to the tumor suppressor p53, Oncogene, vol.15, pp.1363-1367, 1997. ,
A second p53-related protein, p73L, with high homology to p73, Biochem. Biophys. Res. Commun, vol.248, pp.603-607, 1998. ,
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding, Mol. Cell. Biol, vol.12, pp.5581-5592, 1992. ,
Experiments with gene fusions, 1984. ,
Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53, Oncogene, vol.8, pp.2449-2456, 1993. ,
Monitoring adenoviral p53 transduction efficiency by yeast functional assay, Gene Ther, vol.5, pp.339-344, 1998. ,
Response of heat shock element within the human HSP70 promoter to mutated p53 genes, Cell Growth Differ, vol.6, pp.1-8, 1995. ,
Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells, Proc. Natl. Acad. Sci. USA, vol.91, pp.9009-9013, 1994. ,
Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression, Mol. Cell. Biol, vol.13, pp.5186-5194, 1993. ,
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer, EMBO J, vol.11, pp.1383-1390, 1992. ,
function and dysfunction, Cell, vol.70, pp.523-526, 1992. ,
Identification of a novel p53 functional domain that is necessary for efficient growth suppression, Proc. Natl. Acad. Sci. USA, vol.93, pp.15335-15340, 1996. ,
p53 domains: identification and characterization of two autonomous DNA-binding regions, Genes Dev, vol.7, pp.2575-2586, 1993. ,
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, vol.2, pp.305-316, 1998. ,